Invited commentary: how far can epidemiologists get with statistical adjustment?

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Epidemiology

• Publication date

  2005-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/AJE/KWI224PMID 16014781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association between hormone replacement therapy and subsequent stroke: a meta-analysis

  2005cited by this paper
• Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.

  2005influential reference
• Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.

  2004cited by this paper
• A Randomized Double-blind Placebo-controlled Trial

  2004cited by this paper
• National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

  2004cited by this paper
• Commentary: hormones and heart disease: do trials and observational studies address different questions?

  2004cited by this paper
• Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

  2004cited by this paper
• Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study

  2004cited by this paper
• Hormone therapy and the brain: déjà vu all over again?

  2003cited by this paper
• Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women. A randomized controlled trial

  2003cited by this paper
• Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

  2003cited by this paper
• Evidence from randomised trials on the long-term effects of hormone replacement therapy.

  2002cited by this paper
• Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

  2002cited by this paper
• Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial.

  2002cited by this paper
• Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial.

  2002cited by this paper
• Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease

  2002cited by this paper
• Effect of Estrogen Plus Progestin on Progression of Carotid Atherosclerosis in Postmenopausal Women With Heart Disease: HERS B-Mode Substudy

  2002cited by this paper
• Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

  2002cited by this paper
• A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT Atherosclerosis Study

  2002cited by this paper
• Estrogen in the Prevention of Atherosclerosis

  2001cited by this paper
• Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study: A Prospective, Observational Study

  2001cited by this paper
• Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

  2001cited by this paper
• Effect of Oral Postmenopausal Hormone Replacement on Progression of Atherosclerosis: A Randomized, Controlled Trial

  2001cited by this paper
• Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study

  2000cited by this paper
• A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease

  2000cited by this paper
• Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

  2000cited by this paper
• Postmenopausal estrogen replacement therapy and risk of AD

  1999cited by this paper
• Estrogen use and early onset Alzheimer's disease: a population-based study

  1999cited by this paper
• The Heart and Estrogen/Progestin Replacement Study

  1999cited by this paper
• Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging

  1998cited by this paper
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

  1998cited by this paper
• Postmenopausal hormone therapy and mortality.

  1997cited by this paper
• Smoking and oestrogen-replacement therapy as protective factors for Alzheimer's disease.

  1997cited by this paper
• Postmenopausal hormone therapy and mortality.

  1997cited by this paper
• A prospective study of estrogen replacement therapy and the risk of developing Alzheimer''s disease

  1997cited by this paper
• A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease

  1997cited by this paper
• Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials

  1997cited by this paper
• Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

  1996cited by this paper
• Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.

  1996cited by this paper
• Prospective study of exogenous hormones and risk of pulmonary embolism in women.

  1996cited by this paper
• Estrogen replacement therapy and risk of Alzheimer disease.

  1996cited by this paper
• Lack of postmenopausal estrogen replacement therapy and the risk of dementia.

  1995cited by this paper
• Lack of postmenopausal estrogen replacement therapy and the risk of dementia.

  1995cited by this paper
• Postmenopausal estrogen therapy and cardiovascular disease.

  1992cited by this paper
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

  1992cited by this paper
• Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study.

  1991cited by this paper
• Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆

  1991influential reference
• A prospective study of postmenopausal estrogen therapy and coronary heart disease.

  1985cited by this paper
• Use of Postmenopausal Hormones and Risk of Myocardial Infarction

  1981cited by this paper

• Framework for the Use of External Controls to Evaluate Treatment Outcomes in Precision Oncology Trials

  2024cites this paper
• The information in covariate imbalance in studies of hormone replacement therapy

  2021cites this paper
• Real-world evidence: the devil is in the detail

  2020cites this paper
• Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study

  2019cites this paper
• Dullaart, R. P. F. (2019). Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization

  2019cites this paper
• Genetically elevated gamma-glutamyltransferase and Alzheimer's disease

  2018cites this paper
• Effectiveness of integrated care model for type 2 diabetes: A population-based study in Reggio Emilia (Italy)

  2018cites this paper
• Erratum to: Comparison of body mass index, waist circumference, and waist-height ratio in predicting functional outcome following ischemic stroke

  2017cites this paper
• Comparison of body mass index, waist circumference, and waist-height ratio in predicting functional outcome following ischemic stroke

  2017cites this paper
• Hormone Therapy Use and Risk of Chronic Disease in the Nurses’ Health Study: A Comparative Analysis With the Women's Health Initiative

  2017cites this paper
• BMI body mass index CARDIoGRAM Coronary Artery Disease Genome wide Replication and Meta-analyses CHD coronary heart disease CI confidence interval CVD cardiovascular disease GIANT Genetic Investigation of ANthropometric Traits GLGC Global Lipids Genetics Consortium GWAS genome-wide association studi

  2016cites this paper
• Genetically predicted 17beta-estradiol and cardiovascular risk factors in women: a Mendelian randomization analysis using young women in Hong Kong and older women in the Guangzhou Biobank Cohort Study.

  2016cites this paper
• Serum total bilirubin levels and coronary heart disease--Causal association or epiphenomenon?

  2015cites this paper
• Circulating Total Bilirubin and Risk of Incident Cardiovascular Disease in the General Population

  2015cites this paper
• The inc ident user design in comparative effec tiveness research

  2013cites this paper
• The incident user design in comparative effectiveness research

  2013cites this paper
• Intervention and (Re)Invention for Women in Menopause: Cultural Norms, Hormone Therapy and Female Subjectivity

  2012cites this paper
• Comparison of Outcomes by Modality for Critically Ill Patients Requiring Renal Replacement Therapy: A Single-Centre Cohort Study Adjusting for Time-Varying Illness Severity and Modality Exposure

  2012cites this paper
• Circulating vaspin and its relationship with insulin sensitivity, adiponectin and liver histology in subjects with non-alcoholic steatohepatitis

  2012cites this paper
• Using predictors of hormone therapy use to model the healthy user bias: how does healthy user status influence cognitive effects of hormone therapy?

  2012cites this paper
• Home hemodialysis and mortality risk in Australian and New Zealand populations.

  2011cites this paper
• Age at menarche and menopause : their correlates and association with selected cardiovascular disease risk factors among 300,000 Chinese women in the China Kadoorie Biobank

  2011cites this paper
• Intensive Hemodialysis and Mortality Risk in Australian and New Zealand Populations.

  2011cites this paper
• The Spread of Evidence-Poor Medicine via Flawed Social-Network Analysis

  2010cites this paper
• C-reactive protein and vascular risk: from March to Jupiter.

  2010cites this paper
• Lipoprotein(a) and the risk of vascular disease

  2010cites this paper
• Don't rush to judge: drawing conclusions about treatment based on observational studies.

  2009cites this paper
• Opiates for the Matches: Matching Methods for Causal Inference

  2009cites this paper
• Markers of Inflammation and Risk of Coronary Heart Disease

  2009cites this paper
• Effectiveness of Valsartan for Treatment of Hypertension: Patient Profiling and Hierarchical Modeling of Determinants and Outcomes (the Preview Study)

  2009cites this paper
• Functional Limitations, Socioeconomic Status, and All‐Cause Mortality in Moderate Alcohol Drinkers

  2009cites this paper
• The replacement of the replacement in menopause: hormone therapy, controversies, truth and risk.

  2009cites this paper
• Triglycerides and coronary heart disease: have recent insights yielded conclusive answers?

  2009cites this paper
• Mendelian randomisation and cardiovascular disease

  2009cites this paper
• De Testimonio: on the evidence for decisions about the use of therapeutic interventions.

  2008cites this paper
• Survival Analysis

  2008cites this paper
• Statistical adjustment for a measure of healthy lifestyle doesn’t yield the truth about hormone therapy

  2008cites this paper
• Clinical Practice of Menopausal Medicine: How & Why? Menopause & the Role of Hormone Therapy in Indian Women

  2008cites this paper
• De testimonio: on the evidence for decisions about the use of therapeutic interventions.

  2008cites this paper
• On regression adjustments to experimental data

  2008cites this paper
• Do patients’ preferences matter?

  2008cites this paper
• Differential dietary nutrient intake according to hormone replacement therapy use: an underestimated confounding factor in epidemiologic studies?

  2007cites this paper
• Recent epidemiological evidence relevant to the clinical management of the menopause

  2007cites this paper
• Persistence of contradicted claims in the literature.

  2007cites this paper
• Bibliography. Current world literature. Women's health.

  2006cites this paper
• Transportation noise and cardiovascular risk

  2006cites this paper
• Cardiovascular risk and hormone replacement therapy

  2006cites this paper
• Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies

  2006cites this paper
• Prentice et al. Respond to “How Far Can Epidemiologists Get with Statistical Adjustment?”

  2005cites this paper
• (2018). Genetically elevated gamma-glutamyltransferase and Alzheimer's disease. Experimental Gerontology, 106, 61-66.

  year unknowncites this paper
• Oasis or Mirage ?

  year unknowncites this paper
• Experimental Gerontology

  year unknowncites this paper